Anti‐epidermal growth factor receptor monoclonal antibody plus palliative chemotherapy as a first‐line treatment for recurrent or metastatic nasopharyngeal carcinoma

BACKGROUND: Platinum‐based chemotherapy is the standard of care as first‐line treatment for recurrent or metastatic nasopharyngeal carcinoma (RM‐NPC); however, the prognosis of patients with RM‐NPC remains poor. The aim of this study was to evaluate the role of anti‐epidermal growth factor receptor...

Descripción completa

Detalles Bibliográficos
Autores principales: Chen, Chen, Zhou, Yixin, Zhang, Xuanye, Fu, Sha, Lin, Zuan, Fang, Wenfeng, Yang, Yunpeng, Huang, Yan, Zhao, Hongyun, Hong, Shaodong, Zhang, Li
Formato: Online Artículo Texto
Lenguaje:English
Publicado: John Wiley and Sons Inc. 2020
Materias:
Clinical Cancer Research
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7050081/
https://www.ncbi.nlm.nih.gov/pubmed/31955525
http://dx.doi.org/10.1002/cam4.2838

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7050081/
https://www.ncbi.nlm.nih.gov/pubmed/31955525
http://dx.doi.org/10.1002/cam4.2838

Ejemplares similares